A phase I study to assess safety, pharmacokinetics and pharmacodynamics of a topical multipurpose prevention insert containing tenofovir alafenamide fumarate and elvitegravir dosed vaginally Meeting Abstract

publication date

  • February 1, 2021

webpage

published in

volume

  • 24